Peripheral Blood Profiling to Screen Patients for Lung Cancer or Lung Cancer Recurrence

Trial Purpose and Description

The purpose of this study is to screen patients at risk for lung cancer, or lung cancer recurrence using a novel sequencing technique to detect fragments of mutated DNA in the peripheral blood.

Yale University School of Medicine

Start Date: 09/03/2014

End Date: 09/30/2024

Last Updated: 06/22/2018

Study HIC#: 1407014379

Get Involved

For more information about this study, contact:
Kristine Tyc
+1 203-737-4697

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


Daniel Boffa

Principal Investigator